Comparative Outcomes of Esophageal Stent Placement in Esophageal Cancer Patients: A Prospective Study of 183 Cases
PDF

Keywords

Esophageal cancer
Esophageal stent
SEMS
Dysphagia palliation
Stent migration

Date

How to Cite

1.
Salem AE, Abosheaishaa H, Meribout S, et al. Comparative Outcomes of Esophageal Stent Placement in Esophageal Cancer Patients: A Prospective Study of 183 Cases. ASIDE GI. 2025;2(1):7-13. doi:10.71079/ASIDE.GI.09242544

Abstract

Introduction: Esophageal stent placement is a vital, minimally invasive procedure for alleviating dysphagia and enabling smoother food passage. It offers immediate relief, reduces hospital stays, and enhances quality of life for high-risk patients. Effective for both malignant and benign conditions, stenting is cost-efficient and requires skilled professionals for optimal outcomes. This study examines outcomes of various stent types in esophageal cancer patients, evaluating efficacy, safety, and quality-of-life impacts.

Methods: Between January and December 2022, 183 patients with esophageal cancer were enrolled from three tertiary healthcare facilities. Patients were divided into three groups based on the esophageal stent used: self-expanding metallic stents (SEMS, n = 84), self-expanding plastic stents (SEPS, n = 61), and fully covered self-expanding metallic stents (FCSEMS, n = 38). All stent placements were performed under endoscopic guidance, with follow-up assessments at 1 week, 1 month, 3 months, and 6 months to evaluate stent patency, dysphagia relief, and complications.

Results: Technical success rates were high: SEMS 96.4%, SEPS 95.1%, and FCSEMS 97.4%. Immediate dysphagia relief occurred in 87.4% of patients. FCSEMS had a significantly longer median patency duration (8.0 months) compared to SEMS (6.3 months) and SEPS (5.6 months). Additionally, SEPS exhibited a higher migration rate (13.1%), while overall complications were noted in 18.0% of patients.

Conclusions: Esophageal stent placement effectively palliates dysphagia in cancer patients. FCSEMS shows advantages with prolonged patency, yet careful stent selection is essential to optimize patient outcomes. These findings underscore the importance of individualized treatment planning and regular monitoring to achieve optimal outcomes.

PDF

References

1. Lorenzoni V, Chaturvedi AK, Vignat J, Laversanne M, Bray F, Vaccarella S. The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020. Cancer Epidemiol Biomarkers Prev. 2022: 2054 [PMID: 36173880, https://doi.org/10.1158/1055-9965.EPI-22-0642]

2. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024: 12 [PMID: 38230766, https://doi.org/10.3322/caac.21820]

3. Papadakis MA, McPhee SJ, Rabow MW, McQuaid KR, Gandhi M. Authors. Current Medical Diagnosis & Treatment 2024. New York, NY: McGraw-Hill Education; 2024.

4. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF, Jr. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003: 1404 [PMID: 13130116, https://doi.org/10.1093/jnci/djg047]

5. Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018: 210 [PMID: 27986415, https://doi.org/10.1016/j.asjsur.2016.10.005]

6. Committee ASoP, Evans JA, Early DS, Chandraskhara V, Chathadi KV, Fanelli RD, Fisher DA, Foley KQ, Hwang JH, Jue TL, Pasha SF, Sharaf R, Shergill AK, Dominitz JA, Cash BD, American Society for Gastrointestinal E. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc. 2013: 328 [PMID: 23410694, https://doi.org/10.1016/j.gie.2012.10.001]

7. Repici A, Hassan C, Sharma P, Conio M, Siersema P. Systematic review: the role of self-expanding plastic stents for benign oesophageal strictures. Aliment Pharmacol Ther. 2010: 1268 [PMID: 20236257, https://doi.org/10.1111/j.1365-2036.2010.04301.x]

8. Siddiqui AA, Loren D, Dudnick R, Kowalski T. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci. 2007: 823 [PMID: 17253137, https://doi.org/10.1007/s10620-006-9513-6]

9. Lee S, Osugi H, Tokuhara T, Takemura M, Kaneko M, Tanaka Y, Fujiwara Y, Nishizawa S, Iwasaki H, Suehiro S. Self-expandable metallic stent for unresectable malignant strictures in the esophagus and cardia. Jpn J Thorac Cardiovasc Surg. 2005: 470 [PMID: 16200886, https://doi.org/10.1007/s11748-005-0089-4]

10. Kinsman KJ, DeGregorio BT, Katon RM, Morrison K, Saxon RR, Keller FS, Rosch J. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc. 1996: 196 [PMID: 8857133, https://doi.org/10.1016/s0016-5107(96)70315-2]

11. Steyerberg EW, Homs MY, Stokvis A, Essink-Bot ML, Siersema PD, Group SS. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc. 2005: 333 [PMID: 16111947, https://doi.org/10.1016/s0016-5107(05)01587-7]

12. Bick BL, Imperiale TF, Johnson CS, DeWitt JM. Endoscopic suturing of esophageal fully covered self-expanding metal stents reduces rates of stent migration. Gastrointest Endosc. 2017: 1015 [PMID: 28396273, https://doi.org/10.1016/j.gie.2017.03.1545]

13. Conigliaro R, Battaglia G, Repici A, De Pretis G, Ghezzo L, Bittinger M, Messmann H, Demarquay JF, Togni M, Blanchi S, Filiberti R, Conio M. Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol. 2007: 195 [PMID: 17301645, https://doi.org/10.1097/MEG.0b013e328013a418]

14. Dormann AJ, Eisendrath P, Wigginghaus B, Huchzermeyer H, Deviere J. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy. 2003: 207 [PMID: 12584638, https://doi.org/10.1055/s-2003-37252]

15. Petruzziello L, Costamagna G. Stenting in esophageal strictures. Dig Dis. 2002: 154 [PMID: 12566618, https://doi.org/10.1159/000067479]

16. Mbah N, Philips P, Voor MJ, Martin RCG, 2nd. Optimal radial force and size for palliation in gastroesophageal adenocarcinoma: a comparative analysis of current stent technology. Surg Endosc. 2017: 5076 [PMID: 28444492, https://doi.org/10.1007/s00464-017-5571-4]

17. Sabharwal T, Morales JP, Salter R, Adam A. Esophageal cancer: self-expanding metallic stents. Abdom Imaging. 2005: 456 [PMID: 15688108, https://doi.org/10.1007/s00261-004-0277-1]

18. So H, Ahn JY, Han S, Jung K, Na HK, Lee JH, Jeong KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Efficacy and Safety of Fully Covered Self-Expanding Metal Stents for Malignant Esophageal Obstruction. Dig Dis Sci. 2018: 234 [PMID: 29147877, https://doi.org/10.1007/s10620-017-4839-9]

19. Spaander MCW, van der Bogt RD, Baron TH, Albers D, Blero D, de Ceglie A, Conio M, Czako L, Everett S, Garcia-Pagan JC, Gines A, Jovani M, Repici A, Rodrigues-Pinto E, Siersema PD, Fuccio L, van Hooft JE. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Endoscopy. 2021: 751 [PMID: 33930932, https://doi.org/10.1055/a-1475-0063]

20. Kang Y. A Review of Self-Expanding Esophageal Stents for the Palliation Therapy of Inoperable Esophageal Malignancies. Biomed Res Int. 2019: 9265017 [PMID: 31080835, https://doi.org/10.1155/2019/9265017]

21. Lee JW, Yang SG, Na K. Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer. Int J Pharm. 2012: 276 [PMID: 22366483, https://doi.org/10.1016/j.ijpharm.2012.02.016]

22. Shaikh M, Choudhury NR, Knott R, Garg S. Engineering Stent Based Delivery System for Esophageal Cancer Using Docetaxel. Mol Pharm. 2015: 2305 [PMID: 25936529, https://doi.org/10.1021/mp500851u]

23. Dai Y, Li C, Xie Y, Liu X, Zhang J, Zhou J, Pan X, Yang S. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014: CD005048 [PMID: 25354795, https://doi.org/10.1002/14651858.CD005048.pub4]

24. Guo SR, Wang ZM, Zhang YQ, Lei L, Shi JM, Chen KM, Yu Z. In vivo evaluation of 5-fluorouracil-containing self-expandable nitinol stent in rabbits: Efficiency in long-term local drug delivery. J Pharm Sci. 2010: 3009 [PMID: 20091819, https://doi.org/10.1002/jps.22066]

25. Lei L, Liu X, Guo S, Tang M, Cheng L, Tian L. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors. J Control Release. 2010: 45 [PMID: 20566400, https://doi.org/10.1016/j.jconrel.2010.05.017]

26. Wilson JL, Louie BE, Farivar AS, Vallieres E, Aye RW. Fully covered self-expanding metal stents are effective for benign esophagogastric disruptions and strictures. J Gastrointest Surg. 2013: 2045 [PMID: 24065368, https://doi.org/10.1007/s11605-013-2357-4]

27. Das KK, Hasak S, Elhanafi S, Visrodia KH, Ginsberg GG, Ahmad NA, Hollander T, Lang G, Kushnir VM, Mullady DK, Abu Dayyeh BK, Buttar NS, Wong Kee Song LM, Kochman ML, Chandrasekhara V. Performance and Predictors of Migration of Partially and Fully Covered Esophageal Self-Expanding Metal Stents for Malignant Dysphagia. Clin Gastroenterol Hepatol. 2021: 2656 [PMID: 32898705, https://doi.org/10.1016/j.cgh.2020.09.010]

28. Didden P, Spaander MC, Kuipers EJ, Bruno MJ. Safety of stent placement in recurrent or persistent esophageal cancer after definitive chemoradiotherapy: a case series. Gastrointest Endosc. 2012: 426 [PMID: 22657402, https://doi.org/10.1016/j.gie.2012.03.004]

29. Reijm AN, Didden P, Schelling SJC, Siersema PD, Bruno MJ, Spaander MCW. Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time. Endoscopy. 2019: 18 [PMID: 29991071, https://doi.org/10.1055/a-0644-2495]

30. Adler DG. Esophageal Stents: Placement, Complications, Tips, and Tricks. Video Journal and Encyclopedia of GI Endoscopy. 2013: 66 https://doi.org/10.1016/s2212-0971(13)70030-x]

31. Sabharwal T, Morales JP, Irani FG, Adam A, Cardiovascular C, Interventional Radiological Society of E. Quality improvement guidelines for placement of esophageal stents. Cardiovasc Intervent Radiol. 2005: 284 [PMID: 15886931, https://doi.org/10.1007/s00270-004-0344-6]

32. Mwachiro M, Parker R, Lando J, Simel I, Chol N, Ranketi S, Chepkwony R, Pyego L, Chepkirui C, Chepkemoi W, Fleischer D, Dawsey S, Topazian M, Burgert S, White R. Predictors of adverse events and early mortality after esophageal stent placement in a low resource setting: a series of 3823 patients in Kenya. Endosc Int Open. 2022: E479 [PMID: 35433219, https://doi.org/10.1055/a-1783-9829]

33. May A, Hahn EG, Ell C. Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin Gastroenterol. 1996: 261 [PMID: 8771419, https://doi.org/10.1097/00004836-199606000-00004]

34. Siersema PD, Schrauwen SL, van Blankenstein M, Steyerberg EW, van der Gaast A, Tilanus HW, Dees J, Rotterdam Esophageal Tumor Study G. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc. 2001: 579 [PMID: 11677473, https://doi.org/10.1067/mge.2001.118716]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Ahmed E. Salem, Hazem Abosheaishaa, Sarah Meribout, Morad Zaaya, Carla Barberan Parraga, Kantash Kumar, Aye Cherry, Mohammed Abusuliman, Mohamed Eldesouki, Omar Abdelhalim, Yuriy Tsirlin, Aaron Z. Tokayer